Vaccine Therapy for Unresectable Chordoma
In this phase II clinical trial, adult patients with inoperable chordoma who are scheduled to undergo radiation therapy will be randomly assigned to receive a yeast-based vaccine that targets a protein called brachyury or a placebo injection.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/1041767/syndication
- Syndication ID: 4249
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Wednesday, March 23, 2016 at 10:21 PM
- Date Syndication Updated: Monday, August 05, 2019 at 07:39 PM
Embed Code Snippet
To get the embed code snippet please Login.
